Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03655106 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Catheter Length Survivability
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
NCT03655106 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 270 participants.
The verdict
NCT03655106, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
Study Summary
In patients with difficult IV access, ultrasound-guided catheter insertion is a preferred technique. However, many peripheral catheters fail and must be replaced, adding extra pain and difficulty for the patient, and requiring more healthcare provider time to maintain. In preliminary studies, we determined that catheters which extend further into the vein have a smaller failure rate. This study will compare two lengths of catheters to see if the longer catheters have better survival in a population of patients who have difficult IV access. Patients will be randomized to receive a standard length or extra-long venous catheter, which will be monitored daily for functionality during the patient's hospital course.
Interventions
- DEVICE Standard Long IV 4.78 cm 20 g catheter
- DEVICE Ultra-Long IV 6.35 cm 20 g catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2019-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03655106
The ClinicalTrials.gov registry entry for NCT03655106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Long IV 4.78 cm 20 g catheter is the first listed.
NCT03655106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03655106 about?
NCT03655106 is a clinical study titled "Ultrasound Guided Catheter Length Survivability". In patients with difficult IV access, ultrasound-guided catheter insertion is a preferred technique. However, many peripheral catheters fail and must be replaced, adding extra pain and difficulty for the patient, and requiring more healthcare provider time to maintain. In preliminary studies, we det...
What is the current status of trial NCT03655106?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2018-10-29. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT03655106?
The interventions under investigation include: Standard Long IV 4.78 cm 20 g catheter (DEVICE), Ultra-Long IV 6.35 cm 20 g catheter (DEVICE).
Who is sponsoring clinical trial NCT03655106?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.